Coherent pipeline for biomarker discovery using mass spectrometry and bioinformatics.
BACKGROUND
Robust biomarkers are needed to improve microbial identification and diagnostics. Proteomics methods based on mass spectrometry can be used for the discovery of novel biomarkers through their high sensitivity and specificity. However, there has been a lack of a coherent pipeline connecting biomarker discovery with established approaches for evaluation and validation. We propose such a pipeline that uses in silico methods for refined biomarker discovery and confirmation.


RESULTS
The pipeline has four main stages: Sample preparation, mass spectrometry analysis, database searching and biomarker validation. Using the pathogen Clostridium botulinum as a model, we show that the robustness of candidate biomarkers increases with each stage of the pipeline. This is enhanced by the concordance shown between various database search algorithms for peptide identification. Further validation was done by focusing on the peptides that are unique to C. botulinum strains and absent in phylogenetically related Clostridium species. From a list of 143 peptides, 8 candidate biomarkers were reliably identified as conserved across C. botulinum strains. To avoid discarding other unique peptides, a confidence scale has been implemented in the pipeline giving priority to unique peptides that are identified by a union of algorithms.


CONCLUSIONS
This study demonstrates that implementing a coherent pipeline which includes intensive bioinformatics validation steps is vital for discovery of robust biomarkers. It also emphasises the importance of proteomics based methods in biomarker discovery.
Al-Shahib
Ali
A
Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK. ali.al-shahib@hpa.org.uk
Misra
Raju
R
Ahmod
Nadia
N
Fang
Min
M
Shah
Haroun
H
Gharbia
Saheer
S
D000465:Algorithms; D001426:Bacterial Proteins / Q000032:analysis / Q000502:physiology; D015415:Biomarkers / Q000032:analysis*; D003014:Clostridium botulinum / Q000737:chemistry; D019295:Computational Biology; D017124:Conserved Sequence; D016208:Databases, Factual; D013058:Mass Spectrometry / Q000379:methods*; D040901:Proteomics / Q000379:methods*; D012680:Sensitivity and Specificity; D013045:Species Specificity
D001426:Bacterial Proteins; D015415:Biomarkers
Nat Methods. 2007 Mar;4(3):207-14
17327847
Anaerobe. 2008 Oct;14(4):242-9
18621134
BMC Bioinformatics. 2006 Jul 26;7:358
16869977
Clin Cancer Res. 2008 Oct 1;14(19):6246-52
18829504
Methods Enzymol. 1996;266:460-80
8743700
Methods Mol Biol. 2007;367:87-119
17185772
Proteomics. 2005 Aug;5(13):3475-90
16047398
Bioinformatics. 2005 May 15;21(10):2200-9
15784749
J Mol Biol. 1990 Oct 5;215(3):403-10
2231712
Electrophoresis. 1999 Dec;20(18):3551-67
10612281
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
24226387
J Bacteriol. 2007 Feb;189(3):818-32
17114256
J Med Microbiol. 2010 Mar;59(Pt 3):273-284
19926729
J Proteome Res. 2004 Sep-Oct;3(5):1082-5
15473699
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W182-5
17526522
Mol Cell Proteomics. 2007 Sep;6(9):1599-608
17533222
Mol Cell Proteomics. 2008 May;7(5):962-70
18216375
J Proteomics Bioinform. 2009 Jun 1;2(6):262-273
19779596
Bioinformatics. 2004 Jun 12;20(9):1466-7
14976030